Antitumor activities of conjugates of mitomycin C with estradiol benzoate and estradiol via glutaric acid in suspension dosage form

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 10, 2002, Pages 1373-1377

  Ishiki, Nobuyuki ^a   Onishi, Hiraku ^a   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Antitumor activity; E glu MMC; EB glu MMC; Suspension dosage form

Indexed keywords

ANTINEOPLASTIC AGENT; ESTRADIOL; ESTRADIOL BENZOATE; GLUTARIC ACID; MITOMYCIN C; ANTINEOPLASTIC ANTIBIOTIC; DRUG DERIVATIVE; ESTRADIOL 3-BENZOATE; GLUTARIC ACID DERIVATIVE; MITOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM; FEMALE; LEUKEMIA; MALE; MOUSE; NONHUMAN; SARCOMA; ANIMAL; DBA MOUSE; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA P 388; METHODOLOGY; SARCOMA 180;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOSAGE FORMS; ESTRADIOL; FEMALE; GLUTARATES; INJECTIONS, INTRAPERITONEAL; LEUKEMIA P388; MALE; MICE; MICE, INBRED DBA; MITOMYCIN; SARCOMA 180; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036781939     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1373     Document Type: Article

References (19)

1. Ozaki M., Matsuda M., Muramatsu S. Jpn. Pharmacol. Ther., 8, 3707-3710 (1980).
2. Yamanaka H., Shida K., Jpn. J. Cancer Chemother., 11, 537-544 (1984).
3. Yamanaka H., Imai K., Suzuki T., Yuasa H., Takahashi E., Jpn. J. Can-Chemother., 11, 2106-2114 (1984).
4. Masui O., Sakauchi K., Tamura H., Suzuki F., Wada N., Asano K., Enomoto S., Hotla T., Ohsawa N., Proceedings of the Japanese Cancer Association 45th Annual Meeting, Sapporo, 1986, p. 379.
5. Tamura H., Sakauchi K., Asano K., Enomoto S., Hotta T., Fujita H., Clin. Rep., 20, 1835-1846 (1986).
6. Tamura H., Sakauchi K., Masui O., Asano K., Enomoto S., Hotta T., Fujita H., Clin. Rep., 20, 1847-1863 (1986).
7. Hashida M., Kato A., Kojima T., Muranishi S., Sezaki H., Tanigawa N., Satomura K., Hikasa Y., Gann, 72, 226-234 (1981).
8. Kato A., Takakura Y., Hashida M., Kimura T., Sezaki H., Chem. Pharm. Bull., 30, 2951-2957 (1982).
9. Sasaki H., Fukumoto M., Hashida M., Kimura T., Sezaki H., Chem. Pharm. Bull., 31, 4083-4090 (1983).
10. Tanaka T., Kaneo Y., Iguchi S., Bioconjugate Chem., 2, 261-269 (1991).
11. Tanaka T., Kaneo Y., Shiramoto S., Iguchi S., Biol. Pharm. Bull., 16, 1270-1275 (1993).
12. Takakura Y., Takagi A., Hashida M., Sezaki H., Pharm. Res., 4, 293-300 (1987).
13. Ishiki N., Onishi H., Machida Y., Chem. Pharm. Bull., 45, 1345-1349 (1997).
14. Ishiki N., Onishi H., Machida Y., Biol. Pharm. Bull., 20, 1096-1102 (1997).
15. Ishiki N., Onishi H., Machida Y., Biol. Pharm. Bull., 21, 1180-1186 (1998).
16. Wada T., Asano K., Enomoto S., Hotta T., Clin. Rep., 20, 1985-1988 (1986).
17. Imai R., Morimoto M., Marumo H., Kobayashi T., Tsuruo T., Inaba M., Tsukagoshi S., Sakurai Y., Gann, 72, 944-949 (1981).
18. Imai R., Morimoto M., J. Antibiot., 36, 559-565 (1983).
19. Noguchi A., Takahashi T., Yamaguchi T., Kitamura K., Takakura Y., Hashida M., Sezaki H., Jpn. J. Cancer Res., 82, 219-226 (1991).